Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study
An Bras Dermatol
.
2026 May-Jun;101(3):501353.
doi: 10.1016/j.abd.2026.501353.
Epub 2026 Apr 22.
Authors
Burhan Engin
1
,
Yusuf Demir
2
,
Gurbuz Yildirim
2
,
Fatma Zehra Diken
2
,
Bengusu Yildiz
2
,
Zekayi Kutlubay
2
,
Server Serdaroglu
2
Affiliations
1
Department of Dermatology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Electronic address: burhanengin2000@yahoo.com.
2
Department of Dermatology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
PMID:
42025118
PMCID:
PMC13123483
DOI:
10.1016/j.abd.2026.501353
No abstract available